Furthermore, while the studies by Doyle and colleagues suggested that NLRP3 could be used as a protective agent in AMD, other studies have found that NLRP3 activation/consequent increase in active IL-1β is pro-angiogenic and promotes VEGF-induced AMD pathologies (83). This evidence concerns the gene VEGFA and age-related macular degeneration.